Proneuron Biotechnologies
is headquartered in New York, New York. Proneuron Biotechnologies has a revenue of $36.2M, and 122 employees. Proneuron Biotechnologies's main competitors are Thebuonicontifund, Buoniconti Fund To Cure Paraly and Linus Pharma. Proneuron Biotechnologies has 1 followers on Owler.Proneuron Biotechnologies
is headquartered in New York, New York. Proneuron Biotechnologies has a revenue of $36.2M, and 122 employees. Proneuron Biotechnologies's main competitors are Thebuonicontifund, Buoniconti Fund To Cure Paraly and Linus Pharma. Proneuron Biotechnologies has 1 followers on Owler.
CEO
Add
News
Feb 16, 2020
BioPortfolio
Proneuron Biotechnologies: Proneuron to sue Teva for billions in Copaxone damages
Feb 16, 2020
FirstWord Pharma
Proneuron Biotechnologies: Proneuron to sue Teva for billions in Copaxone damages - (Globes via NewsPoints Desk)
Apr 26, 2017
BioPortfolio
Proneuron Biotechnologies: Teva embroiled in Copaxone dosage levels dispute
